Please use this identifier to cite or link to this item:
Scopus Web of ScienceĀ® Altmetric
Type: Journal article
Title: Stop-codon read-through for patients affected by a lysosomal storage disorder
Author: Brooks, D.
Muller, V.
Hopwood, J.
Citation: Trends in Molecular Medicine, 2006; 12(8):367-373
Publisher: Elsevier Sci Ltd
Issue Date: 2006
ISSN: 1471-4914
Abstract: Lysosomal storage disorders are a group of inherited diseases that can result in severe and progressive pathology due to a specific lysosomal dysfunction. Current treatment strategies include bone-marrow transplantation, substrate reduction, chemical-chaperone and enzyme-replacement therapy. However, each of these treatments has its limitations. Enhanced stop-codon read-through is a potential alternative or adjunct therapeutic strategy for treating lysosomal-storage-disorder patients. Premature stop-codon mutations have been identified in a large cohort of patients with a lysosomal storage disorder, making stop-codon read-through a possible treatment for this disease. In lysosomal-storage-disorder cells (mucopolysaccharidosis type I, alpha-L-iduronidase deficient), preclinical studies have shown that gentamicin induced the read-through of premature stop codons, resulting in enzyme activity that reduced substrate storage.
Keywords: Humans; Lysosomal Storage Diseases; Gentamicins; Codon, Terminator; Codon, Nonsense; Gene Expression Regulation; Models, Biological
RMID: 0020061368
DOI: 10.1016/j.molmed.2006.06.001
Appears in Collections:Paediatrics publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.